Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001477449-24-000153

EVP, CORPORATE DEVELOPMENT sold 1,627 shares at $11.16 ($18,152)

  • EVP, CORPORATE DEVELOPMENT acquired 5,504 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Turitz Andrew · EVP, CORPORATE DEVELOPMENT

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-31 Exercise or conversion : show line 1 in the form +1,056 34,838 D
2024-05-31 Exercise or conversion : show line 2 in the form +1,348 36,186 D
2024-05-31 Exercise or conversion : show line 3 in the form +3,100 39,286 D
2024-06-03 Sale : show line 4 in the form −1,627 $11.16 $18,152 37,659 D
Open-market sales · 1,627 sh · avg $11.16 · $18,152

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-05-31 Exercise or conversion : show line 5 in the form Performance Stock Units −1,056 7,397 D
2024-05-31 Exercise or conversion : show line 6 in the form Restricted Stock Units −1,348 4,044 D
2024-05-31 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,100 21,702 D
Loading xslF345X05/wk-form4_1717531608.xml…